core.ac.uk · 2017. 3. 23. · nant tumor in Korea, comprising 3.07% of all malignancy during period of study. Among malignant lymphomas non-Hodgkin's lymphoma accounted for 82% and

Page 1 <img data-url='document/coreacuk-2017-3-23-nant-tumor-in-korea-comprising-307-of-all-malignancy.html?page=1' data-page='1' class='cut-thumb lazyload' alt='Page 1: core.ac.uk · 2017. 3. 23. · nant tumor in Korea, comprising 3.07% of all malignancy during period of study. Among malignant lymphomas non-Hodgkin's lymphoma accounted for 82% and' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader033.cupdf.com/reader033/viewer/2022060910/60a46e31e4d2b25c6d74504c/html5/thumbnails/1.jpg' width='140' height='200' /> Page 2 <img data-url='document/coreacuk-2017-3-23-nant-tumor-in-korea-comprising-307-of-all-malignancy.html?page=2' data-page='2' class='cut-thumb lazyload' alt='Page 2: core.ac.uk · 2017. 3. 23. · nant tumor in Korea, comprising 3.07% of all malignancy during period of study. Among malignant lymphomas non-Hodgkin's lymphoma accounted for 82% and' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader033.cupdf.com/reader033/viewer/2022060910/60a46e31e4d2b25c6d74504c/html5/thumbnails/2.jpg' width='140' height='200' /> Page 3 <img data-url='document/coreacuk-2017-3-23-nant-tumor-in-korea-comprising-307-of-all-malignancy.html?page=3' data-page='3' class='cut-thumb lazyload' alt='Page 3: core.ac.uk · 2017. 3. 23. · nant tumor in Korea, comprising 3.07% of all malignancy during period of study. Among malignant lymphomas non-Hodgkin's lymphoma accounted for 82% and' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader033.cupdf.com/reader033/viewer/2022060910/60a46e31e4d2b25c6d74504c/html5/thumbnails/3.jpg' width='140' height='200' /> Page 4 <img data-url='document/coreacuk-2017-3-23-nant-tumor-in-korea-comprising-307-of-all-malignancy.html?page=4' data-page='4' class='cut-thumb lazyload' alt='Page 4: core.ac.uk · 2017. 3. 23. · nant tumor in Korea, comprising 3.07% of all malignancy during period of study. Among malignant lymphomas non-Hodgkin's lymphoma accounted for 82% and' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader033.cupdf.com/reader033/viewer/2022060910/60a46e31e4d2b25c6d74504c/html5/thumbnails/4.jpg' width='140' height='200' /> Page 5 <img data-url='document/coreacuk-2017-3-23-nant-tumor-in-korea-comprising-307-of-all-malignancy.html?page=5' data-page='5' class='cut-thumb lazyload' alt='Page 5: core.ac.uk · 2017. 3. 23. · nant tumor in Korea, comprising 3.07% of all malignancy during period of study. Among malignant lymphomas non-Hodgkin's lymphoma accounted for 82% and' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader033.cupdf.com/reader033/viewer/2022060910/60a46e31e4d2b25c6d74504c/html5/thumbnails/5.jpg' width='140' height='200' /> Page 6 <img data-url='document/coreacuk-2017-3-23-nant-tumor-in-korea-comprising-307-of-all-malignancy.html?page=6' data-page='6' class='cut-thumb lazyload' alt='Page 6: core.ac.uk · 2017. 3. 23. · nant tumor in Korea, comprising 3.07% of all malignancy during period of study. Among malignant lymphomas non-Hodgkin's lymphoma accounted for 82% and' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader033.cupdf.com/reader033/viewer/2022060910/60a46e31e4d2b25c6d74504c/html5/thumbnails/6.jpg' width='140' height='200' /> Page 7 <img data-url='document/coreacuk-2017-3-23-nant-tumor-in-korea-comprising-307-of-all-malignancy.html?page=7' data-page='7' class='cut-thumb lazyload' alt='Page 7: core.ac.uk · 2017. 3. 23. · nant tumor in Korea, comprising 3.07% of all malignancy during period of study. Among malignant lymphomas non-Hodgkin's lymphoma accounted for 82% and' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader033.cupdf.com/reader033/viewer/2022060910/60a46e31e4d2b25c6d74504c/html5/thumbnails/7.jpg' width='140' height='200' />

core.ac.uk · 2017. 3. 23. · nant tumor in Korea, comprising 3.07% of all malignancy during period of study. Among malignant lymphomas non-Hodgkin's lymphoma accounted for 82% and

Documents